CellSource Co

CellSource Co Diluted EPS

The Diluted Earnings per Share of CellSource Co (4880.T) as of Oct 27, 2026 is 0.54 JPY. In the previous year, Diluted Earnings per Share was 12.01 JPY — a change of -95.52% (lower).

Diluted EPS

0.54JPY

YoY

-95.52%

Last updated:

Diluted Earnings per Share of CellSource Co is 2025 0.54 JPY. Diluted Earnings per Share of CellSource Co was 2024 12.01 JPY. It decreases by -95.52% lower compared to the previous year.

The CellSource Co Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2018
9.72 JPY
Jan 1, 2019
11.55 JPY
Jan 1, 2020
14.30 JPY
Jan 1, 2021
33.90 JPY
Jan 1, 2022
52.97 JPY
Jan 1, 2023
47.59 JPY
Jan 1, 2024
12.01 JPY
Jan 1, 2025
0.54 JPY
The CellSource Co Diluted EPS history
YEARDiluted EPSYoY
0.54JPY-95.52%
12.01JPY-74.75%
47.59JPY-10.17%
52.97JPY+56.26%
33.90JPY+137.07%
14.30JPY+23.79%
11.55JPY+18.84%
9.72JPY+73.61%
5.60JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CellSource Co Stock analysis

What does CellSource Co do? CellSource Co., Ltd. generates revenue through its Regenerative Medicine Related business segment, which provides contracted services for processing tissues and cells from fat and blood to medical institutions, along with support services for regenerative medicine laws and regulations related to safety assurance. The company also sells medical equipment within this segment. The Consumer business segment focuses on selling cosmetics and facial products directly to general consumers. Both segments operate under the company's brand without additional brand names mentioned in the description. The Regenerative Medicine Related business segment targets medical institutions and regulatory compliance support for regenerative medicine safety, while the Consumer business segment serves general consumers seeking cosmetics and facial care products. The company's products include processed tissue and cell services, regulatory support, medical equipment, and consumer skincare items, all sold under the CellSource brand. CellSource Co., Ltd. employs 109 full-time employees to manage its two business segments, with the Regenerative Medicine Related segment handling medical services and equipment sales, and the Consumer segment focusing on direct-to-consumer product sales. The company's revenue streams are derived from these two distinct operational areas without any additional external partnerships or third-party brands. CellSource Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CellSource Co stock

Diluted Earnings per Share of CellSource Co is 0.54 JPY in 2025.

Diluted Earnings per Share of CellSource Co changed from 12.01 JPY to 0.54 JPY, representing a -95.52% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share CellSource Co since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — CellSource Co

All Key Metrics — CellSource Co